T-cell prolymphocytic leukemia: survival improves with alemtuzemab but stem cell transplant eligibility "counts"even more.Estella Matutes,Aaron PolliackLEUKEMIA & LYMPHOMA(2016)引用 2|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要